Article Information
History
- April 29, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Elena Solopova1,*,
- Wilber Romero-Fernandez1,*,
- Hannah Harmsen2,
- Lissa Ventura-Antunes1,
- Emmeline Wang1,
- Alena Shostak1,
- Jose Maldonado3,
- Manus Donahue1,
- Daniel Schultz4,
- Thomas M. Coyne5,
- Andreas Charidimou6 and
- Matthew Schrag1,7,8,*
- 1Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee
- 2Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
- 3Vanderbilt Neurovisualization Lab, Vanderbilt University, Nashville Tennessee
- 4Final Diagnosis: Private Autopsy Florida - Forensic Pathology Lab, Tampa, Florida
- 5Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida
- 6Department of Neurology, Boston University, Boston, Massachusetts
- 7The Vanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee
- 8Vanderbilt Memory and Alzheimer’s Center, Vanderbilt University Medical Center, Nashville, Tennessee
- ↵* Corresponding author; email: matthew.schrag{at}vanderbilt.edu
↵* These authors contributed equally.
Posted April 29, 2023.
Fatal Iatrogenic Cerebral Amyloid-Related Encephalitis in a patient treated with lecanemab for Alzheimer’s disease: neuroimaging and neuropathology
